Loading...
Daiichi Sankyo Company, Limited
DSKYF•PNK
Healthcare
Drug Manufacturers - General
$24.34
$0.69(2.92%)
Daiichi Sankyo Company, Limited (DSKYF) Financial Performance & Income Statement Overview
Review Daiichi Sankyo Company, Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.77%
↑ 17.77%
Operating Income Growth
43.34%
↑ 43.34%
Net Income Growth
47.34%
↑ 47.34%
Operating Cash Flow Growth
-91.02%
↓ 91.02%
Operating Margin
14.65%
↑ 14.65%
Gross Margin
77.96%
↑ 77.96%
Net Profit Margin
15.68%
↑ 15.68%
ROE
17.95%
↑ 17.95%
ROIC
10.23%
↑ 10.23%
Daiichi Sankyo Company, Limited (DSKYF) Income Statement & Financial Overview
Review Daiichi Sankyo Company, Limited's (DSKYF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $518.69B | $484.84B | $446.55B | $436.18B |
| Cost of Revenue | $94.34B | $128.38B | $98.03B | $95.05B |
| Gross Profit | $424.35B | $356.46B | $348.52B | $341.13B |
| Gross Profit Ratio | $0.82 | $0.74 | $0.78 | $0.78 |
| R&D Expenses | $133.32B | $109.32B | $92.61B | $100.71B |
| SG&A Expenses | $208.21B | $185.63B | $162.24B | $175.12B |
| Operating Expenses | $341.53B | $295.05B | $254.85B | $248.15B |
| Total Costs & Expenses | $435.87B | $423.43B | $380.56B | $343.20B |
| Interest Income | $2.87B | $13.46B | $0.00 | $19.13B |
| Interest Expense | $7.08B | -$7.45B | $11.62B | $1.97B |
| Depreciation & Amortization | $17.98B | $17.37B | $16.68B | $16.61B |
| EBITDA | $104.47B | $78.78B | $110.60B | $109.59B |
| EBITDA Ratio | $0.20 | $0.16 | $0.25 | $0.25 |
| Operating Income | $82.82B | $61.41B | $93.67B | $92.98B |
| Operating Income Ratio | $0.16 | $0.13 | $0.21 | $0.21 |
| Other Income/Expenses (Net) | -$3.42B | $21.003B | -$11.36B | $17.22B |
| Income Before Tax | $79.41B | $82.41B | $82.31B | $110.20B |
| Income Before Tax Ratio | $0.15 | $0.17 | $0.18 | $0.25 |
| Income Tax Expense | -$6.52B | $20.49B | $21.09B | $24.82B |
| Net Income | $87.15B | $61.93B | $61.29B | $85.38B |
| Net Income Ratio | $0.17 | $0.13 | $0.14 | $0.20 |
| EPS | $46.31 | $32.75 | $31.97 | $44.60 |
| Diluted EPS | $46.31 | $32.75 | $31.94 | $44.57 |
| Weighted Avg Shares Outstanding | $1.88B | $1.89B | $1.92B | $1.91B |
| Weighted Avg Shares Outstanding (Diluted) | $1.88B | $1.89B | $1.92B | $1.92B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan